Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Genomic and Transcriptomic Alterations Associated with STAT3 Activation in Head and Neck Cancer.
Journal: PloS one
Published: July 27, 2016
MAPK1E322K mutation increases head and neck squamous cell carcinoma sensitivity to erlotinib through enhanced secretion of amphiregulin.
Journal: Oncotarget
Published: March 02, 2016
Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell Carcinoma.
Journal: JAMA oncology
Published: July 17, 2015
Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancer.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 08, 2014
Cisplatin-Based Chemotherapy Options for Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck.
Journal: Clinical medicine insights. Therapeutics
Published: November 26, 2013
Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers.
Journal: Cancer discovery
Published: April 27, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026